2,3-Dihydro-1-benzofuran-5-ols as analogues of alpha-tocopherol that inhibit in vitro and ex vivo lipid autoxidation and protect mice against central nervous system trauma.
A series of alpha-tocopherol analogues was synthesized with potential therapeutic value for such pathological conditions as stroke and trauma. A set of criteria such as the inhibition of in vitro lipid peroxidation, superoxyl radical scavenging, and brain penetration, as measured by ex vivo inhibition of lipid peroxidation, was applied to select the most effective compound. 2,3-Dihydro-2,2,4,6,7-pentamethyl-3-[(4-methylpiperazino)methyl]-1 - benzofuran-5-ol dihydrochloride (22) was selected because of its superior antioxidant properties and better brain penetration. This compound also protected mice against the effects of head injury. The criteria thus turned out to be useful for the characterization of a neuroprotective analogue of alpha-tocopherol.
Marion Merrell Dow Research Institute, Strasbourg, France.
J M
JM
Grisar
F N
FN
Bolkenius
M A
MA
Petty
J
J
Verne
D000818:Animals; D001572:Benzofurans / Q000737:chemistry*; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000378:metabolism; D006259:Craniocerebral Trauma / Q000188:drug therapy* / Q000378:metabolism; D004353:Drug Evaluation, Preclinical; D016166:Free Radical Scavengers; D015227:Lipid Peroxidation / Q000187:drug effects*; D008297:Male; D051379:Mice; D013481:Superoxides / Q000378:metabolism; D014810:Vitamin E / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D001572:Benzofurans; D016166:Free Radical Scavengers; D013481:Superoxides; D014810:Vitamin E